flavien charpentier
INSERM U1087 Institut du Thorax
Nantes, France
Review Editor
Pharmacology of Ion Channels and Channelopathies
Editors
INSERM U1087 Institut du Thorax
Nantes, France
Review Editor
Pharmacology of Ion Channels and Channelopathies
University of Poitiers
Poitiers, France
Review Editor
Pharmacology of Ion Channels and Channelopathies
Genentech Inc.
San Francisco, United States
Review Editor
Pharmacology of Ion Channels and Channelopathies
Guangzhou University of Chinese Medicine
Guangzhou, China
Review Editor
Pharmacology of Ion Channels and Channelopathies
China Medical University
Shenyang, China
Review Editor
Pharmacology of Ion Channels and Channelopathies
College of Pharmacy, The Catholic University of Korea
Bucheon, Republic of Korea
Review Editor
Pharmacology of Ion Channels and Channelopathies
Stanford University
Stanford, United States
Review Editor
Pharmacology of Ion Channels and Channelopathies
Institut National de la Santé et de la Recherche Médicale (INSERM)
Paris, France
Review Editor
Pharmacology of Ion Channels and Channelopathies
New York University
New York City, United States
Review Editor
Pharmacology of Ion Channels and Channelopathies
BioIntervene,Inc
Brisbane, United States
Review Editor
Pharmacology of Ion Channels and Channelopathies
Columbia University
New York City, United States
Review Editor
Pharmacology of Ion Channels and Channelopathies
University of Bari Aldo Moro
Bari, Italy
Review Editor
Pharmacology of Ion Channels and Channelopathies
Thomas Jefferson University
Philadelphia, United States
Review Editor
Pharmacology of Ion Channels and Channelopathies
Victor Chang Cardiac Research Institute
Sydney, Australia
Review Editor
Pharmacology of Ion Channels and Channelopathies
Institut National de la Santé et de la Recherche Médicale (INSERM)
Paris, France
Review Editor
Pharmacology of Ion Channels and Channelopathies
Bahçeşehir University
Istanbul, Türkiye
Review Editor
Pharmacology of Ion Channels and Channelopathies